Neurology and Neurosurgery - Global Neurology Academy

401-416 of 481

Sudden Unexplained Death in Epilepsy (SUDEP): Risks and Prevention
Sudden Unexplained Death in Epilepsy (SUDEP): Risks and Prevention
Clinician's Roundtable
Sudden Unexplained Death in Epilepsy (SUDEP): Risks and Prevention
Andrew Wilner, MD, FACP, FAAN; Elizabeth Donner, MD
- Andrew Wilner, MD, FACP, FAAN
- Elizabeth Donner, MD
Radiation Nation: The Effects of Cell Phones on Children's Brains
Radiation Nation: The Effects of Cell Phones on Children's Brains
Primary Care Today
Radiation Nation: The Effects of Cell Phones on Children's Brains
Brian P. McDonough, MD, FAAFP
- Brian P. McDonough, MD, FAAFP
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Resources
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Biophysics of Minimizing Brain Damage After Hemorrhagic Stroke
The Biophysics of Minimizing Brain Damage After Hemorrhagic Stroke
Primary Care Today
The Biophysics of Minimizing Brain Damage After Hemorrhagic Stroke
Brian P. McDonough, MD, FAAFP; Annalisa Scimemi
- Brian P. McDonough, MD, FAAFP
- Annalisa Scimemi
The Diagnostic Challenges of Spinal Cord Lesions in MS
The Diagnostic Challenges of Spinal Cord Lesions in MS
CME/CE
The Diagnostic Challenges of Spinal Cord Lesions in MS
Jiwon Oh, MD, PhD
- Jiwon Oh, MD, PhD
Head's Up! Why Wearing Bike Helmets Can't Be Overlooked
Head's Up! Why Wearing Bike Helmets Can't Be Overlooked
Primary Care Today
Head's Up! Why Wearing Bike Helmets Can't Be Overlooked
Brian P. McDonough, MD, FAAFP; Howard Spiva
- Brian P. McDonough, MD, FAAFP
- Howard Spiva
Reducing the Burden of MS Treatment
Reducing the Burden of MS Treatment
Resources
Reducing the Burden of MS Treatment
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Resources
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Resources
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Multiple Sclerosis Physician Resources
Multiple Sclerosis Physician Resources
Resources
Multiple Sclerosis Physician Resources
Optimizing MS Treatment Options
Optimizing MS Treatment Options
Interviews
Optimizing MS Treatment Options
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Global Neurology Academy
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Establishing Partnerships to Optimize Patient Outcomes
Establishing Partnerships to Optimize Patient Outcomes
Interviews
Establishing Partnerships to Optimize Patient Outcomes
Highlights from the MAGNIMS Consensus Guidelines
Highlights from the MAGNIMS Consensus Guidelines
Interviews
Highlights from the MAGNIMS Consensus Guidelines
Immunologic Effects on Metabolic Syndrome and MS
Immunologic Effects on Metabolic Syndrome and MS
Interviews
Immunologic Effects on Metabolic Syndrome and MS
Neck and Back Pain: When Should You Refer Your Patients to a Neurosurgeon?
Neck and Back Pain: When Should You Refer Your Patients to a Neurosurgeon?
Medical Breakthroughs from Penn Medicine
Neck and Back Pain: When Should You Refer Your Patients to a Neurosurgeon?
Matt Birnholz, MD; Patrick J. Connolly, MD
- Matt Birnholz, MD
- Patrick J. Connolly, MD

26/11